Pyoung Hwa Park

ARID1A-mutated ovarian cancers depend on HDAC6 activity

Benjamin G. Bitler, Shuai Wu, Pyoung Hwa Park et al. · Nature Cell Biology · 2017 · 231 citations

Medicine, Molecular Genetics, Oncology +12

EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition

Sergey Karakashev, Takeshi Fukumoto, Bo Zhao et al. · Cancer Cell · 2020 · 153 citations · Full text

Medicine, Molecular Biology, Oncology +16

CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity

Sergey Karakashev, Hengrui Zhu, Shuai Wu et al. · Nature Communications · 2018 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer

Takeshi Fukumoto, Pyoung Hwa Park, Shuai Wu et al. · Cell Reports · 2018 · 100 citations · Full text

Medicine, Cancer Biology, Oncology +12

SWI/SNF catalytic subunits’ switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells

Shuai Wu, Nail Fatkhutdinov, Takeshi Fukumoto et al. · Nature Communications · 2018 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +15